PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy
Author:
Funder
EpicentRx Inc
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference20 articles.
1. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies;Elad;CA Cancer J Clin,2022
2. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life;Elting;Cancer,2008
3. Radiation treatment breaks and ulcerative mucositis in head and neck cancer patients;Russo;Oncologist,2008
4. Cost of radiation-induced oral mucositis in head and neck cancer patients: An administrative claims analysis;Hoffbauer;J Manag Care Spec Ph,2020
5. A hypothesis for the pathogenesis of radiation-induced oral mucositis: When biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment;Sonis;Support Care Cancer,2021
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023;European Journal of Medicinal Chemistry;2023-11
2. Severe Oral Mucositis: Companies Put Their Money where the Mouth is and Vie for a Marketshare;Onco Zine – The International Oncology Network;2023-09-11
3. TGF-β: the apex predator of immune checkpoints;Future Oncology;2023-09
4. Data Management 101 for drug developers: A peek behind the curtain;Clinical and Translational Science;2023-07-06
5. A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma;Frontiers in Oncology;2023-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3